Value and Application of Trimodality Therapy or Definitive Concurrent Chemoradiotherapy in Thoracic Esophageal Squamous Cell Carcinoma

Cancer - United States
doi 10.1002/cncr.30823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Effectiveness of Esophagectomy in Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Definitive Radiotherapy or Concurrent Chemoradiotherapy Through Intensity-Modulated Radiation Therapy Techniques

Cancer
Cancer ResearchOncology
2017English

Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients

World Journal of Surgical Oncology
SurgeryOncology
2018English

YAP1 Amplification as a Prognostic Factor of Definitive Chemoradiotherapy in Nonsurgical Esophageal Squamous Cell Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Lymph Node Enlargement After Definitive Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma After Concurrent Chemoradiotherapy

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Sensitivity Value of Hematological Markers in Patients Receiving Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of the Oropharynx

Journal of Otolaryngology of Japan
Otorhinolaryngology
2007English

The Prognostic Value of Nodal Skip Metastasis in Resectable Thoracic Esophageal Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Supraclavicular and/or Celiac Lymph Node Metastases From Thoracic Esophageal Squamous Cell Carcinoma Did Not Compromise Survival Following Neoadjuvant Chemoradiotherapy and Surgery

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy